HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natural killer cell function and interferon generation in patients with primary immunodeficiencies.

Abstract
Patients with primary immunodeficiency disorders were evaluated for three aspects of natural defense: natural killer (NK) cells which lyse HSV-infected fibroblasts [NK(HSV-FS)], NK cells which lyse K562 tumor targets [NK(K562)], and interferon-alpha generation. In addition, capacity to make interferon upon challenge with other commonly used inducers was also evaluated. Most patients with severe combined immunodeficiency disease (SCID) and deficits of both T- and B-cell function demonstrated normal NK function with one or both targets. Six of eight SCID patients generated interferon-alpha at or below the lower limit of normal while only two made clearly normal levels. Six of 10 patients with Wiskott-Aldrich syndrome (WAS) had normal NK(K562) and five of 10 generated normal levels of interferon-alpha but all had severely deficient NK(HSV-FS). Patients with Bruton's agammaglobulinemia demonstrated normal NK and interferon generation, as did patients with common variable immunodeficiency, even when subdivided into patients with T-cell proliferative deficiencies and those with only hypogammaglobulinemia. Natural defense parameters may help categorize patients with SCID and WAS and help define these heterogeneous diseases.
AuthorsC Messina, D Kirkpatrick, P A Fitzgerald, R J O'Reilly, F P Siegal, C Cunningham-Rundles, M Blaese, J Oleske, S Pahwa, C Lopez
JournalClinical immunology and immunopathology (Clin Immunol Immunopathol) Vol. 39 Issue 3 Pg. 394-404 (Jun 1986) ISSN: 0090-1229 [Print] United States
PMID3698344 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Interferon Type I
Topics
  • Agammaglobulinemia (immunology)
  • Humans
  • Immunity, Cellular
  • Immunity, Innate
  • Immunologic Deficiency Syndromes (immunology)
  • Interferon Type I (biosynthesis)
  • Killer Cells, Natural (immunology)
  • Wiskott-Aldrich Syndrome (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: